B Cell News and Research

RSS

Scientists discover the Achilles heel of chemotherapy-resistant ovarian cancer

Women diagnosed with ovarian cancer may initially respond well to chemotherapy, but the majority of them will develop resistance to treatment and die from the disease.

21 Feb 2024

Vitamin D3 and phytochemicals team up for immune boost and aging defense, study finds

Review highlights the synergistic effects of vitamin D3 and phytochemicals in promoting immune balance, reducing inflammation, supporting gut health, and combating aging, emphasizing the importance of these nutrients for longevity and vitality.

21 Feb 2024

COVID-19's neurological effects linked to immune response, not direct viral attack

Study identifies neurocognitive symptoms in COVID-19 patients as a reaction to systemic infection rather than direct brain infection, highlighting changes in the brain's immune response and synaptic organization.

21 Feb 2024

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.

21 Feb 2024

Study highlights an immunological mechanism underlying Long COVID

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression.

21 Feb 2024

Largest genetic study on circulating retinol reveals new insights into its impact on health

Study presents the largest genome-wide association analysis on circulating retinol, identifying genes beyond the primary transport system that influence retinol levels and its broad impacts on health, including potential protective roles against schizophrenia and effects on various clinical phenotypes.

21 Feb 2024

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Announcing a new publication for Acta Materia Medica journal. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but pose a challenge of immune-related adverse events (irAEs), particularly endocrine toxicity, that can severely compromise patient well-being.

21 Feb 2024

Intramolecular bivalent glues: A promising avenue for protein degradation

Living cells resemble highly organized small towns - in addition to energy production, transportation systems, and construction, cells also require efficient waste disposal.

21 Feb 2024

New mechanism discovered: B cells' contribution to immune tolerance in thymus gland

Immune cells must learn not to attack the body itself. A team of researchers from the Technical University of Munich (TUM) and the Ludwig Maximilian University of Munich (LMU) has discovered a previously unknown mechanism behind this: other immune cells, the B cells, contribute to the "training" of the T cells in the thymus gland.

21 Feb 2024

Study reveals mechanism of drug targeting protein modification in tumor suppressor genes

Researchers have revealed the mechanism of a drug shown to be effective in treating certain types of cancer, which targets a protein modification silencing the expression of multiple tumor suppressor genes.

21 Feb 2024

Scientists develop 3D-printable gelatin materials for reconstructive and plastic surgery

Researchers from IOCB Prague and Ghent University have been working on improving the properties of gelatin-based materials, thereby expanding the possibilities of their use mainly in medicine.

21 Feb 2024

Mutation in E. coli bacteria linked to severe disease

Queensland researchers have discovered that a mutation allows some E. coli bacteria to cause severe disease in people while other bacteria are harmless, a finding that could help to combat antibiotic resistance.

21 Feb 2024

Nose cartilage-based knee joint treatment project receives €2.3 million funding

Treating knee joint defects with cartilage from the nose: The University Hospital in Würzburg is working on the approval of this procedure.

21 Feb 2024

Physical inactivity and inflammation drive age-related gene changes in skeletal muscles

New research indicates that some age-related changes in gene and protein expression in the skeletal muscles of older individuals may be affected more by physical inactivity and chronic inflammation than primary aging, or intrinsic maturational processes.

21 Feb 2024

Mitochondrial activation enhances cardiac regeneration therapy

Regenerative therapy to treat heart failure is more effective when the mitochondria of the regenerative cells are activated prior to treatment.

21 Feb 2024

Microplastics detected in all human placenta samples

A flurry of recent studies has found that microplastics are present in virtually everything we consume, from bottled water to meat and plant-based food.

21 Feb 2024

IκBζ protein holds potential for treating autoimmune conditions

Our immune system is remarkably powerful. It quickly assembles teams of cells to eliminate threats inside our bodies.

21 Feb 2024

Pioneering cell-based treatment for melanoma offered at Siteman Cancer Center

Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.

20 Feb 2024

Novel treatment strategy shows promise against common liver cancer in children

Hepatoblastoma (HB) is the most common liver cancer in children. Researchers and physicians in the field are concerned because in the last decade HB has been rising rapidly worldwide and has seen the most rapid increase among all pediatric solid tumors.

20 Feb 2024

Scientists identify new therapeutic approach for combating neurodegenerative diseases

A team led by scientists at the Case Western Reserve University School of Medicine has identified a new therapeutic approach for combating neurodegenerative diseases, offering hope of improved treatments for Alzheimer's disease, Parkinson's disease, Vanishing White Matter disease and multiple sclerosis, among others.

20 Feb 2024

B Cell News and Research

Scientists discover the Achilles heel of chemotherapy-resistant ovarian cancer

Vitamin D3 and phytochemicals team up for immune boost and aging defense, study finds

COVID-19's neurological effects linked to immune response, not direct viral attack

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

Study highlights an immunological mechanism underlying Long COVID

Largest genetic study on circulating retinol reveals new insights into its impact on health

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Intramolecular bivalent glues: A promising avenue for protein degradation

New mechanism discovered: B cells' contribution to immune tolerance in thymus gland

Study reveals mechanism of drug targeting protein modification in tumor suppressor genes

Scientists develop 3D-printable gelatin materials for reconstructive and plastic surgery

Mutation in E. coli bacteria linked to severe disease

Nose cartilage-based knee joint treatment project receives €2.3 million funding

Physical inactivity and inflammation drive age-related gene changes in skeletal muscles

Mitochondrial activation enhances cardiac regeneration therapy

Microplastics detected in all human placenta samples

IκBζ protein holds potential for treating autoimmune conditions

Pioneering cell-based treatment for melanoma offered at Siteman Cancer Center

Novel treatment strategy shows promise against common liver cancer in children

Scientists identify new therapeutic approach for combating neurodegenerative diseases

Immunology eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News